Basic Information
Glactone Pharma Develops New STAT3 Inhibitors for Immuno-Oncology and Drug-Resistant Cancers
Glactone Pharma AB
Skåne,Sweden
less than 15 people
January 01, 2012
jan.tornell@aqilion.com
Enterprise Profile
Technology
Concept